顺铂
DNA损伤
细胞凋亡
DNA修复
槲皮素
雷达51
癌症研究
活力测定
细胞毒性
分子生物学
MTT法
化学
生物
DNA
体外
化疗
生物化学
抗氧化剂
遗传学
作者
Faezeh Malakoti,Maryam Majidinia,Yasin Ahmadi,Bahman Yousefi,Darioush Shanebandi
出处
期刊:Drug research
[Thieme Medical Publishers (Germany)]
日期:2022-06-20
卷期号:72 (07): 378-384
被引量:6
摘要
Abstract Background Osteosarcoma (OS) patients are commonly treated with chemotherapeutic agents like cisplatin (Cis). Quercetin with fewer side effects can improve the potency of chemotherapy and be used in combinational therapies. Herein, we aimed to evaluate the effects of Cis plus quercetin on DNA damage response (DDR), DNA repair, and apoptosis in Saos-2 cells. Methods The effects of Cis and quercetin single or in combination on Saos-2 cell viability and the cytotoxicity of the drugs were measured by MTT assay. The expression of DDR and repair components including P53, ATM, ATR, RAD51, and H2AX, and also miR-22 were analyzed by real-time PCR. The rate of apoptosis was measured by flow cytometry. Results Quercetin potentiated the cytotoxic effects of Cis in Saos-2 cells. The IC50 of Cis reduced from 6.12 µM to 4.25 µM. The combination of quercetin and Cis was associated with the up-regulation of miR-22 and DDR components, including P53, ATM, ATR, and H2AX as well as the down-regulation of RAD51. Moreover, this combined regimen significantly induced apoptosis in Saos-2 cells compared to mono drugs. Conclusion The co-treatment of quercetin and Cis can accelerate DNA damage, DNA damage response, and apoptosis while interfering with the DNA repair process in Saos-2 cells. Moreover, this combination provokes the tumor suppressor miR-22 expression in these cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI